Table of Contents
ISRN Analytical Chemistry
Volume 2012, Article ID 673564, 6 pages
http://dx.doi.org/10.5402/2012/673564
Research Article

Improvement of Water Solubility of Josamycin by Inclusion Complex with 𝜸 -Cyclodextrin

1Medicinal Chemistry Research Team, Faculty of Medicine and Pharmacy, University Mohammed V, Souissi, BP 6203, Rabat, Morocco
2Pharmaceutical and Toxicological analysis Research Team, Laboratory of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, University Mohammed V, Souissi, BP 6203, Rabat, Morocco
3Centre de Recherche en Epidémiologie Clinique et Essais thérapeutiques, Faculty of Medicine and Pharmacy, University Mohammed V, Souissi, BP 6203, Rabat, Morocco

Received 2 November 2011; Accepted 20 November 2011

Academic Editors: D. Heimler and V. Stefov

Copyright © 2012 J. El Harti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Saito, H. Ueda, M. Abe, T. Sato, D. Sherril, and S. D. Christian, “Inclusion complexation of Triton X-100 with α-,β- and γ- cyclodextrins,” Colloids and Surfaces A, vol. 135, no. 1–3, pp. 103–108, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. E. M. M. Del Valle, “Cyclodextrins and their uses: a review,” Process Biochemistry, vol. 39, no. 9, pp. 1033–1046, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Li, Y. Zhang, Y. Wu, X. Xiong, and Y. Zhang, “Inclusion complex of trimethoprim with β-cyclodextrin,” Journal of Pharmaceutical and Biomedical Analysis, vol. 39, no. 3-4, pp. 824–829, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. O. A. Soliman, K. Kimura, F. Hirayama et al., “Amorphous spironolactone-hydroxypropylated cyclodextrin complexes with superior dissolution and oral bioavailability,” International Journal of Pharmaceutics, vol. 149, no. 1, pp. 73–83, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. N. B. Naidu, K. P. R. Chowdary, K. V. R. Murthy, V. Satyanarayana, A. R. Hayman, and G. Becket, “Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems,” Journal of Pharmaceutical and Biomedical Analysis, vol. 35, no. 1, pp. 75–86, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. S. Scalia, A. Molinari, A. Casolari, and A. Maldotti, “Complexation of the sunscreen agent, phenylbenzimidazole sulphonic acid with cyclodextrins: effect on stability and photo-induced free radical formation,” European Journal of Pharmaceutical Sciences, vol. 22, no. 4, pp. 241–249, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. Tommasini, D. Raneri, R. Ficarra, M. L. Calabrò, R. Stancanelli, and P. Ficarra, “Improvement in solubility and dissolution rate of flavonoids by complexation with β-cyclodextrin,” Journal of Pharmaceutical and Biomedical Analysis, vol. 35, no. 2, pp. 379–387, 2004. View at Publisher · View at Google Scholar · View at PubMed
  8. J. Veillaverde, J. Pérez-Martínez, C. Maqueda, J. M. Ginés, and E. Morillo, “Inclusion complexes of α- and γ-cyclodextrins and the herbecide norflurazon: I. Preparation and characerization II. Enhanced solubilisation and removal from soils,” Chemosphere, vol. 60, pp. 656–664, 2005. View at Google Scholar
  9. K. Terao, D. Nakata, H. Fukumi et al., “Enhancement of oral bioavailability of coenzyme Q10 by complexation with γ-cyclodextrin in healthy adults,” Nutrition Research, vol. 26, no. 10, pp. 503–508, 2006. View at Publisher · View at Google Scholar
  10. G. Rondini, C. E. Cocuzza, M. Cianflone, A. Lanzafame, L. Santini, and R. Mattina, “Bacteriological and clinical efficacy of various antibiotics used in the treatment of streptococcal pharyngitis in Italy. An epidemiological study,” International Journal of Antimicrobial Agents, vol. 18, no. 1, pp. 9–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Kasahara, A. Nishikawa, F. Furukawa et al., “A chronic toxicity study of josamycin in F344 rats,” Food and Chemical Toxicology, vol. 40, no. 7, pp. 1017–1022, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Gattringer, R. Sauermann, H. Lagler et al., “Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary,” International Journal of Antimicrobial Agents, vol. 24, no. 3, pp. 92–95, 2004. View at Google Scholar · View at Scopus
  13. European Phrmacopeia 5.0 Josamycin propionate General notices (1) apply to all monographs and other texts 1861–1862.
  14. T. Loftsson, “Cyclodextrins and the biopharmaceutics classification system of drugs,” Journal of Inclusion Phenomena, vol. 44, no. 1–4, pp. 63–67, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Brewster and T. Loftsson, “Cyclodextrins as pharmaceutical solubilizers,” Advanced Drug Delivery Reviews, vol. 59, no. 7, pp. 645–666, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. C. Anselmi, M. Centini, M. Ricci et al., “Analytical characterization of a ferulic acid/γ-cyclodextrin inclusion complex,” Journal of Pharmaceutical and Biomedical Analysis, vol. 40, no. 4, pp. 875–881, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. N. Sarisuta, M. Kumpugdee, B. W. Müller, and S. Puttipipatkhachorn, “Physico-chemical characterization of interactions between erythromycin and various film polymers,” International Journal of Pharmaceutics, vol. 186, no. 2, pp. 109–118, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Gandhi, O. Pillai, R. Thilagavathi, B. Gopalakrishnan, C. L. Kaul, and R. Panchagnula, “Characterization of azithromycin hydrates,” European Journal of Pharmaceutical Sciences, vol. 16, no. 3, pp. 175–184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Wen, F. Tan, Z. Jing, and Z. Liu, “Preparation and study the 1:2 inclusion complex of carvedilol with β-cyclodextrin,” Journal of Pharmaceutical and Biomedical Analysis, vol. 34, no. 3, pp. 517–523, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Martín, A. León, M. A. Martín, B. del Castillo, and J. C. Menéndez, “Detection and charcterization of cyclodextrin complexes with β-carboline derivatives by spectroscopic techniques,” Journal of Pharmaceutical and Biomedical Analysis, vol. 32, no. 4-5, pp. 991–1001, 2003. View at Google Scholar
  21. R. Ficarra, S. Tommasini, D. Raneri et al., “Study of flavonoids/β-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation,” Journal of Pharmaceutical and Biomedical Analysis, vol. 29, no. 6, pp. 1005–1014, 2002. View at Publisher · View at Google Scholar
  22. A. Zornoza, C. Martín, M. Sánchez, I. Vélaz, and A. Piquer, “Inclusion complexation of glisentide with α-, β- and γ-cyclodextrins,” International Journal of Pharmaceutics, vol. 169, no. 2, pp. 239–244, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. M. D. Veiga and M. Merino, “Interactions of oxyphenbutazone with different cyclodextrins in aqueous medium and in the solid state,” Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 5, pp. 973–982, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Zingone and F. Rubessa, “Preformulation study of the inclusion complex warfarin-β-cyclodextrin,” International Journal of Pharmaceutics, vol. 291, no. 1-2, pp. 3–10, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. X. Wen, Z. Liu, T. Zhu, M. Zhu, K. Jiang, and Q. Huang, “Evidence for the 2:1 molecular recognition and inclusion behaviour between β- and γ-cyclodextrins and cinchonine,” Bioorganic Chemistry, vol. 32, no. 4, pp. 223–233, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. P. L. Dentuto, L. Catucci, P. Cosma et al., “Cyclodextrin/chlorophyll a complexes as supramolecular photosensitizers,” Bioelectrochemistry, vol. 70, no. 1, pp. 39–43, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. Abrahmsén-Alami, E. Alami, J. Eastoe, and T. Cosgrove, “Interaction between a novel gemini surfactant and cyclodextrin: NMR and surface tension studies,” Journal of Colloid and Interface Science, vol. 246, no. 1, pp. 191–202, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. W. Al-Soufi, P. R. Cabrer, A. Jover, R. M. Budal, and J. V. Tato, “Determination of second-order association constants by global analysis of 1H and 13C NMR chemical shifts. Application to the complexation of sodium fusidate and potassium helvolate by β- and γ-cyclodextrin,” Steroids, vol. 68, no. 1, pp. 43–53, 2003. View at Publisher · View at Google Scholar